150 related articles for article (PubMed ID: 16249747)
21. Telomere biology in hematopoiesis and stem cell transplantation.
Gadalla SM; Savage SA
Blood Rev; 2011 Nov; 25(6):261-9. PubMed ID: 21764192
[TBL] [Abstract][Full Text] [Related]
22. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
[TBL] [Abstract][Full Text] [Related]
23. Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients.
Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Bone Marrow Transplant; 2018 Jan; 53(1):69-77. PubMed ID: 28991250
[TBL] [Abstract][Full Text] [Related]
24. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation.
Lee JJ; Nam CE; Kook H; Maciejewski JP; Kim YK; Chung IJ; Park KS; Lee IK; Hwang TJ; Kim HJ
Bone Marrow Transplant; 2003 Nov; 32(9):947-52. PubMed ID: 14561997
[TBL] [Abstract][Full Text] [Related]
25. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
Boettcher S; Wilk CM; Singer J; Beier F; Burcklen E; Beisel C; Ventura Ferreira MS; Gourri E; Gassner C; Frey BM; Schanz U; Skoda RC; Ebert BL; Brummendorf TH; Beerenwinkel N; Manz MG
Blood; 2020 Apr; 135(18):1548-1559. PubMed ID: 32181816
[TBL] [Abstract][Full Text] [Related]
26. Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
Myllymäki M; Redd R; Reilly CR; Saber W; Spellman SR; Gibson CJ; Hu ZH; Wang T; Orr EH; Grenier JG; Chen MM; Steensma DP; Cutler C; De Vivo I; Antin JH; Neuberg D; Agarwal S; Lindsley RC
Blood; 2020 Dec; 136(26):3070-3081. PubMed ID: 33367544
[TBL] [Abstract][Full Text] [Related]
27. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex.
Baerlocher GM; Rovó A; Müller A; Matthey S; Stern M; Halter J; Heim D; Rischewski J; Gratwohl A; Tichelli A
Blood; 2009 Jul; 114(1):219-22. PubMed ID: 19411630
[TBL] [Abstract][Full Text] [Related]
28. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Scott BL; Sandmaier BM; Storer B; Maris MB; Sorror ML; Maloney DG; Chauncey TR; Storb R; Deeg HJ
Leukemia; 2006 Jan; 20(1):128-35. PubMed ID: 16270037
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
30. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
Savani BN; Labopin M; Kröger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socié G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Jun; 101(6):773-80. PubMed ID: 26969081
[TBL] [Abstract][Full Text] [Related]
31. Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation.
Wynn R; Thornley I; Freedman M; Saunders EF
Br J Haematol; 1999 Jun; 105(4):997-1001. PubMed ID: 10554813
[TBL] [Abstract][Full Text] [Related]
32. Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients.
Lewis NL; Mullaney M; Mangan KF; Klumpp T; Rogatko A; Broccoli D
Bone Marrow Transplant; 2004 Jan; 33(1):71-8. PubMed ID: 14704659
[TBL] [Abstract][Full Text] [Related]
33. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.
Mevorach D; Zuckerman T; Reiner I; Shimoni A; Samuel S; Nagler A; Rowe JM; Or R
Biol Blood Marrow Transplant; 2014 Jan; 20(1):58-65. PubMed ID: 24140121
[TBL] [Abstract][Full Text] [Related]
34. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
35. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
[TBL] [Abstract][Full Text] [Related]
36. Influence of telomere length on short-term recovery after allogeneic stem cell transplantation.
Widmann TA; Willmann B; Pfreundschuh M; Beelen DW
Exp Hematol; 2005 Oct; 33(10):1257-61. PubMed ID: 16219549
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
[TBL] [Abstract][Full Text] [Related]
38. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
[TBL] [Abstract][Full Text] [Related]
39. Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo.
Derenzini E; Risso A; Ruella M; Spatola T; Milone G; Pioltelli P; Iori AP; Santarone S; Bosi A; Rambaldi A; Bacigalupo AP; Arcese W; Tarella C
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1387-1394. PubMed ID: 30935966
[TBL] [Abstract][Full Text] [Related]
40. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N
Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
